CN101454440B - 益生菌株以及从其衍生的抗微生物肽 - Google Patents

益生菌株以及从其衍生的抗微生物肽 Download PDF

Info

Publication number
CN101454440B
CN101454440B CN2007800198580A CN200780019858A CN101454440B CN 101454440 B CN101454440 B CN 101454440B CN 2007800198580 A CN2007800198580 A CN 2007800198580A CN 200780019858 A CN200780019858 A CN 200780019858A CN 101454440 B CN101454440 B CN 101454440B
Authority
CN
China
Prior art keywords
st4sa
peptide
streptococcus
bacterial strain
concentration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN2007800198580A
Other languages
English (en)
Chinese (zh)
Other versions
CN101454440A (zh
Inventor
利昂·米尔纳·西奥多·迪克斯
斯韦托斯拉夫·迪米特罗夫·托多罗夫
亨德理特·科诺伊特滋
玛丽莱兹·布林克
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cipla Maeder Plo (pte) Ltd
Original Assignee
Cipla Medpro Res and Dev Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from ZA200604035A external-priority patent/ZA200604035B/xx
Application filed by Cipla Medpro Res and Dev Pty Ltd filed Critical Cipla Medpro Res and Dev Pty Ltd
Publication of CN101454440A publication Critical patent/CN101454440A/zh
Application granted granted Critical
Publication of CN101454440B publication Critical patent/CN101454440B/zh
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N63/00—Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
    • A01N63/50—Isolated enzymes; Isolated proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/46—Streptococcus ; Enterococcus; Lactococcus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biomedical Technology (AREA)
  • Mycology (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Plant Pathology (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Dentistry (AREA)
  • Environmental Sciences (AREA)
  • Immunology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CN2007800198580A 2006-05-28 2007-05-25 益生菌株以及从其衍生的抗微生物肽 Expired - Fee Related CN101454440B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ZA200604035A ZA200604035B (en) 2005-05-31 2006-05-28 Improved grenade launcher
ZA2006/04035 2006-05-28
PCT/IB2007/051982 WO2007138538A2 (en) 2006-05-28 2007-05-25 Probiotic strain and antimicrobial peptide derived therefrom

Publications (2)

Publication Number Publication Date
CN101454440A CN101454440A (zh) 2009-06-10
CN101454440B true CN101454440B (zh) 2013-05-29

Family

ID=38779065

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2007800198580A Expired - Fee Related CN101454440B (zh) 2006-05-28 2007-05-25 益生菌株以及从其衍生的抗微生物肽

Country Status (13)

Country Link
US (2) US7951385B2 (enExample)
EP (1) EP2021457B1 (enExample)
JP (1) JP2009538614A (enExample)
KR (1) KR101521123B1 (enExample)
CN (1) CN101454440B (enExample)
AP (1) AP2841A (enExample)
AU (1) AU2007266675B2 (enExample)
CA (1) CA2647161A1 (enExample)
EA (1) EA017558B1 (enExample)
IL (2) IL195520A0 (enExample)
NO (1) NO20084577L (enExample)
NZ (1) NZ571619A (enExample)
WO (1) WO2007138538A2 (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7951385B2 (en) * 2006-05-28 2011-05-31 Cipla Medpro Research And Development (Pty) Ltd. Probiotic strain and antimicrobial peptide derived therefrom
US8357519B2 (en) * 2008-11-19 2013-01-22 The Ohio State University Methods and processes for producing esters
WO2011045764A1 (en) * 2009-10-15 2011-04-21 Cipla Medpro Research And Development (Pty) Ltd A product for delivering antimicrobially active substances to an infected site
JP5881017B2 (ja) * 2010-11-05 2016-03-09 国立大学法人広島大学 籾殻または玄米から単離された植物乳酸菌およびその利用
WO2012148891A1 (en) * 2011-04-29 2012-11-01 Evonik Degussa Corporation Peptide-lipid conjugates and uses thereof
RU2532227C1 (ru) * 2013-10-23 2014-10-27 Федеральное бюджетное учреждение науки Государственный научный центр прикладной микробиологии и биотехнологии (ФБУН ГНЦ ПМБ) Штамм enterоcoccus mundtii, продуцирующий субстанцию пептидной природы с антилистериозной активностью
RU2599430C1 (ru) * 2015-07-23 2016-10-10 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Горский государственный аграрный университет" ШТАММ ЛАКТОБАКТЕРИЙ Enterococcus mundtii - ПРОДУЦЕНТ МОЛОЧНОЙ КИСЛОТЫ И АНТИБИОТИЧЕСКИХ ВЕЩЕСТВ
US9944960B2 (en) * 2015-11-17 2018-04-17 Premier Research Labs, Lp Process for microbial production of dihydrolipoic acid and extraction of dihydrolipoic acid with edible oils
CN105385636A (zh) * 2015-12-07 2016-03-09 江南大学 一株产细菌素的肠膜明串珠菌及其应用
EP3436156A1 (en) 2016-03-31 2019-02-06 Gojo Industries, Inc. Antimicrobial peptide stimulating cleansing composition
WO2017173241A1 (en) 2016-03-31 2017-10-05 Gojo Industries, Inc. Sanitizer composition with probiotic/prebiotic active ingredient
KR101722255B1 (ko) * 2016-04-22 2017-04-03 주식회사 폴인브레드 쌀과 쌀누룩을 이용한 자연발효종 제조방법
WO2018098152A1 (en) 2016-11-23 2018-05-31 Gojo Industries, Inc. Sanitizer composition with probiotic/prebiotic active ingredient
CN111356760A (zh) * 2017-09-19 2020-06-30 阿德瓦希斯公司 细菌或李斯特菌菌株的冻干组合物和方法
AU2019214149A1 (en) * 2018-01-31 2020-07-09 Nutri Co., Ltd. Prophylactic and/or therapeutic agent for pneumococcal infection
KR102076089B1 (ko) 2018-10-02 2020-02-11 서울대학교 산학협력단 니신 z 생산능이 우수한 락토코커스 락티스 서브스페시스 락티스 ldtm 6804 신균주(kctc 13564bp)
CN109456911B (zh) * 2018-10-10 2019-10-18 南京林业大学 一株蒙氏肠球菌HcM7及其应用
CN110846260B (zh) * 2019-12-18 2021-03-02 江南大学 一株降低生物胺的肉葡萄球菌及其应用
KR20240115407A (ko) * 2023-01-18 2024-07-26 조선대학교산학협력단 오리 유래 항균 펩타이드로부터 설계된 신규 항균 펩타이드 및 이의 용도

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH1084969A (ja) 1996-09-19 1998-04-07 Chemo Sero Therapeut Res Inst ヘモフィルス・パラガリナルム由来新規ポリペプチド及びその製法
US7655775B2 (en) * 1997-09-05 2010-02-02 Canbiocin, Inc. Expression vectors for treating bacterial infections
AU7898700A (en) 1999-10-22 2001-05-08 Shanghai Bio Road Gene Development Ltd. A novel polypeptide-rna binding protein 33 and polynucleotide encoding said polypeptide
GB0027761D0 (en) 2000-11-14 2000-12-27 Nestle Sa Nutritional composition for an immune condition
DE10105347A1 (de) * 2001-02-05 2002-08-22 Nutrinova Gmbh Sorbinsäurepräparat enthaltend Probiotika als Futtermittelzusatz in der Nutztieraufzucht
GB0125535D0 (en) 2001-10-24 2001-12-12 Microbiological Res Authority Mycobacterial genes down-regulated during latency
US6878373B2 (en) 2001-12-03 2005-04-12 Micropure Technologies, Inc. Probiotic composition containing Bacillus cereus RRRL B-30535
JP4111489B2 (ja) * 2002-05-23 2008-07-02 プリマハム株式会社 新規バクテリオシン
WO2004005492A2 (fr) * 2002-07-03 2004-01-15 Galina Gennadievna Alekhina Composition probiotique a base d'une souche d'enterocoques pour moyens de traitement et de prevention et procede de fabrication correspondant
EP1384483A1 (en) * 2002-07-23 2004-01-28 Nestec S.A. Probiotics for treatment of irritable bowel disease (IBS) through improvement of gut neuromuscular function
ITBO20020564A1 (it) 2002-09-06 2004-03-07 Alfa Wassermann Spa Bifidobatteri e preparazioni che li contengono.
US7951385B2 (en) * 2006-05-28 2011-05-31 Cipla Medpro Research And Development (Pty) Ltd. Probiotic strain and antimicrobial peptide derived therefrom

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
JP特开2003-339377A 2003.12.02
Shinichi Kawamoto et al..Biochemical and Genetic Characterization of Mundticin KS, an Antilisterial Peptide Produced by Enterococcus mundtii NFRI 7393.《APPLIED AND ENVIRONMENTAL MICROBIOLOGY》.American Society for Microbiology,2002,第 68 卷(第 8 期),3830-3840. *
ShinichiKawamotoetal..BiochemicalandGeneticCharacterizationofMundticinKS an Antilisterial Peptide Produced by Enterococcus mundtii NFRI 7393.《APPLIED AND ENVIRONMENTAL MICROBIOLOGY》.American Society for Microbiology

Also Published As

Publication number Publication date
EA017558B1 (ru) 2013-01-30
CN101454440A (zh) 2009-06-10
AP2841A (en) 2014-02-28
EP2021457B1 (en) 2015-02-11
AU2007266675B2 (en) 2012-09-06
EA200802409A1 (ru) 2009-10-30
NZ571619A (en) 2011-10-28
KR20090023626A (ko) 2009-03-05
NO20084577L (no) 2008-12-19
WO2007138538A2 (en) 2007-12-06
US20090297482A1 (en) 2009-12-03
IL195520A0 (en) 2011-08-01
AP2008004626A0 (en) 2008-10-31
US8444998B2 (en) 2013-05-21
CA2647161A1 (en) 2007-12-06
JP2009538614A (ja) 2009-11-12
US7951385B2 (en) 2011-05-31
US20110268703A1 (en) 2011-11-03
KR101521123B1 (ko) 2015-05-19
AU2007266675A1 (en) 2007-12-06
IL250634A0 (en) 2017-03-30
WO2007138538A3 (en) 2008-04-17
EP2021457A2 (en) 2009-02-11

Similar Documents

Publication Publication Date Title
CN101454440B (zh) 益生菌株以及从其衍生的抗微生物肽
Tulini et al. Identification and evaluation of the probiotic potential of Lactobacillus paraplantarum FT259, a bacteriocinogenic strain isolated from Brazilian semi-hard artisanal cheese
Mansour et al. Inhibition of Clostridium difficile in mice using a mixture of potential probiotic strains Enterococcus faecalis NM815, E. faecalis NM915, and E. faecium NM1015: novel candidates to control C. difficile infection (CDI)
CN116064326B (zh) 一株能够缓解抑郁情绪的动物双歧杆菌乳亚种gbw8051及其应用
Todorov et al. Bacteriocin production and resistance to drugs are advantageous features for Lactobacillus acidophilus La-14, a potential probiotic strain
CN110004072A (zh) 一株益生性粪肠球菌分离株a3-1及其应用
KR101310123B1 (ko) 헬리코박터 파이로리의 생육을 저해하는 김치 유래 젖산균
JP4457364B2 (ja) 新規な乳酸菌及び当該乳酸菌を使用して加工した各種製品
KR101098946B1 (ko) 신규한 락토바실러스 살리바리우스 균주 및 이를 함유하는 사료첨가제 조성물
KR101364695B1 (ko) 헬리코박터 파이로리의 생육을 저해하는 타락 유래 젖산균
KR101201337B1 (ko) 신규한 락토바실러스속 유산균 복합 균주를 포함하는 사료첨가제
CN109652334A (zh) 一种微生物复合菌剂及其制备方法和应用
Wagner et al. Potential hazards of probiotic bacteria for immunodeficient patients
CN114574405B (zh) 植物乳杆菌菌株wka86及其在制备防治口臭制品方面的用途与制品
CN116925961A (zh) 一株具有增效Bt蛋白杀虫活力和抑菌作用的成团泛菌PxG45及其应用
KR100646938B1 (ko) 헬리코박터 필로리의 정착과 생육 활성을 저해하는락토바실루스 람노서스 아이디씨씨 3201
KR102808726B1 (ko) 프럭토필릭 락트산 생산 박테리아
CN114149942A (zh) 一株东洋芽孢杆菌及其应用
Widodo et al. Human origin Lactobacillus casei isolated from Indonesian infants demonstrating potential characteristics as probiotics in vitro
Al-Aabideen Effect of Probiotic on Motility Factors and Swarming Phenomenon of Proteus mirabilis
KR102003786B1 (ko) 신규한 시가톡신 생성 대장균 특이 박테리오파지 ecoh7 및 이를 포함하는 항균 조성물
SIREESHA CHARACTERIZATION OF DAIRY ORIGIN PROBIOTIC BACILLUS SPECIES
O'Sullivan Bifidobacteria and siderophores produced thereby and methods of use
BUFFALO Dr. ANUKARNA SINGH. ANUKARNA SINGH
CN119685203A (zh) 一种抗幽门螺杆菌的植物乳杆菌及其用途

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C41 Transfer of patent application or patent right or utility model
TR01 Transfer of patent right

Effective date of registration: 20160518

Address after: Cape Town

Patentee after: Cipla Maeder Plo (PTE) Ltd

Address before: Baer vale, South Africa

Patentee before: Cipla Medpro Res And Dev Pty Ltd.

Effective date of registration: 20160518

Address after: Cape Town

Patentee after: Cipla Maeder Plo (PTE) Ltd

Address before: Baer vale, South Africa

Patentee before: Cipla Medpro Res And Dev Pty Ltd.

CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20130529

Termination date: 20190525

CF01 Termination of patent right due to non-payment of annual fee